AD, N., CJ, B., LA, H., NS, L., BE, L., & AC, F. (2021). Editorial: Recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply. Alimentary pharmacology & therapeutics, 54(2), 198. https://doi.org/10.1111/apt.16443
Chicago Style (17th ed.) CitationAD, Nelson, Black CJ, Houghton LA, Lugo-Fagundo NS, Lacy BE, and Ford AC. "Editorial: Recognising the Efficacy of Licensed Drug Therapies for Irritable Bowel Syndrome on Bloating-a Step in the Right Direction for Targeted Treatment? Authors' Reply." Alimentary Pharmacology & Therapeutics 54, no. 2 (2021): 198. https://doi.org/10.1111/apt.16443.
MLA (9th ed.) CitationAD, Nelson, et al. "Editorial: Recognising the Efficacy of Licensed Drug Therapies for Irritable Bowel Syndrome on Bloating-a Step in the Right Direction for Targeted Treatment? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 54, no. 2, 2021, p. 198, https://doi.org/10.1111/apt.16443.